Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group study.

被引：21
|
作者：
Lugtenburg, Pieternella J.
Brown, Peter de Nully
van der Holt, Bronno
D'Amore, Francesco
Koene, Harry R.
Berenschot, Henriette W.
Fijnheer, Rob
Loosveld, Olaf
Bohmer, Lara H.
Pruijt, Hans
Verhoef, Gregor
Hoogendoorn, Mels
de Kan, Romko
Van Imhoff, Gustaaf Willem
van Hooije, Christel
Lam, King H.
de Keizer, Bart
de Jong, Daphne
Hoekstra, Otto S.
Zijlstra, Josee M.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7504
引用
收藏
页数：2
相关论文
共 50 条
  • [31] RITUXIMAB MAINTENANCE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA IN A MULTICENTER PROSPECTIVE RANDOMISED PHASE II STUDY
    Witzens-Harig, M.
    Benner, A.
    Rieger, M.
    McClanahan, F.
    Hensel, M.
    Neben, K.
    Dreger, P.
    Lengfelder, E.
    Schmidt-Wolf, I.
    Kraemer, A.
    Ho, A.
    HAEMATOLOGICA, 2012, 97 : 93 - 94
  • [32] SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB IN COMBINATION WITH CHOP FOR PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM THE PHASE IIIB MABEASE STUDY
    Lugtenburg, P.
    Rueda, A.
    Avivi, I.
    Nagler, A.
    Marolleau, J. -P.
    Tani, M.
    Berenschot, H.
    Osborne, S.
    Smith, R.
    Pfreundschuh, M.
    HAEMATOLOGICA, 2015, 100 : 178 - 179
  • [33] Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma
    Niitsu, Nozomi
    Kohri, Mika
    Hagiwara, Yuki
    Tanae, Ken
    Takahashi, Naoki
    Bessho, Masami
    Okamoto, Masataka
    HEMATOLOGICAL ONCOLOGY, 2010, 28 (02) : 68 - 74
  • [34] Treatment of diffuse large B cell lymphoma with CHOP and rituximab.: Results of a multicenter study with 236 patients.
    De la Serna, J
    Ayala, R
    Canales, M
    Giraldo, P
    de la Cruz-Mora, M
    Rueda, A
    Montalban, C
    Queizan, J
    Garcia-Vela, J
    Feliu, F
    Calle, C
    Hernandez, B
    Hernandez, R
    Solano, F
    Peñalver, J
    Ojanguren, J
    Sanchez-Guilarte, J
    Morante, C
    Nicolas, C
    Roman, A
    Palomera, L
    Diaz-Mediavilla, J
    BLOOD, 2005, 106 (11) : 264B - 264B
  • [35] A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma
    Micallef, I. N.
    Maurer, M. J.
    Nikcevich, D. A.
    Cannon, M.
    Moore, D. F., Jr.
    Kurtin, P.
    Witzig, T. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
    Sehn, Laurie H.
    Martelli, Maurizio
    Trneny, Marek
    Liu, Wenxin
    Bolen, Christopher R.
    Knapp, Andrea
    Sahin, Deniz
    Sellam, Gila
    Vitolo, Umberto
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [37] A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
    Laurie H. Sehn
    Maurizio Martelli
    Marek Trněný
    Wenxin Liu
    Christopher R. Bolen
    Andrea Knapp
    Deniz Sahin
    Gila Sellam
    Umberto Vitolo
    Journal of Hematology & Oncology, 13
  • [38] Final Analysis of GOYA: A Randomized, Open-Label, Phase III Study of Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
    Sahn, Laurie H.
    Martelli, Maurizio
    Trneny, Marek
    Liu, Wenxin
    Bolen, Christopher R.
    Knapp, Andrea
    Sahin, Deniz
    Sellam, Gila
    Vitolo, Umberto
    BLOOD, 2019, 134
  • [39] Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA)
    Vitolo, Umberto
    Trneny, Marek
    Belada, David
    Carella, Angelo M.
    Chua, Neil
    Abrisqueta, Pau
    Demeter, Judit
    Flinn, Ian W.
    Hong, Xiaonan
    Kim, Won Seog
    Pinto, Antonio
    Burke, John M.
    Shi, Yuankai
    Tatsumi, Yoichi
    Oestergaard, Mikkel
    Wenger, Michael K.
    Fingerle-Rowson, Gunter
    Catalani, Olivier
    Nielsen, Tina
    Martelli, Maurizio
    Sehn, Laurie H.
    BLOOD, 2016, 128 (22)
  • [40] Dose-Dense Weekly Rituximab and Standard CHOP Therapy in 123 Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma; Ganken Ariake Lymphoma Study Group Analysis.
    Yokoyama, Masahiro
    Terui, Yasuhito
    Takeuchi, Kengo
    Asai, Hiroaki
    Kodaira, Makoto
    Ueda, Kyoko
    Yamada, Shuhei
    Mishima, Yuko
    Sakajiri, Sakura
    Saotome, Takashi
    Takahashi, Shunji
    Hatake, Kiyohiko
    BLOOD, 2009, 114 (22) : 1423 - 1424
12345